Rep. Kevin Hern (R-OK) disclosed 7 trades:
Traded: Aug 27 | Disclosed: Sep 25

Sold: $NVS ($15K-$50K), $CL ($1K-$15K), $WMT ($1K-$15K), $TJX ($1K-$15K), $PBA ($15K-$50K), $HD ($1K-$15K), $CSX ($1K-$15K)

https://integrityindex.us/candidate/kevin-hern

Seulement 2 semaines après leur dernier tir, l’ #ISRO a entamé la campagne de lancement de leur prochaine mission pour la constellation #NavIC indienne avec #NVS-03.

The weakest areas were healthcare, homebuilders, travel, and parts of software, highlighted by $XLV -2.52%, $ITB -3.05%, and sharp declines in $AMGN, $NVS, $BKNG, and $EXPE.

Key Mover for Sep 8: $NVS (▼-13.93%)
Fell 13.93% on the day, one of the sharpest declines in the universe and a key contributor to healthcare weakness.

Anomalous Activity for Sep 8: $NVS
$NVS pairs heavy activity with weak price action: Capital Flow +5.5σ, Relative Return -5.2σ, Relative Gap -8.2σ. Earlier Capital Flow was already elevated, but today’s downside price-relative readings are the real anomaly.

Anomaly Analysis for Sep 8:
Cross-sectional dispersion is elevated and concentrated in equities. $ROIV leads with Relative Return +7.7σ and Relative Gap +9.7σ, while $NVS and $AMGN pair extreme Capital Flow with weak Relative Return. $MPC extends persistent positive Persistence.

🚨 Novartis Plunges 10%, Headed for Worst Day Ever

Novartis shares are down about 10% and tracking for their steepest one-day loss on record. The selloff…

#NVS

https://stop-fake.org/alerts/novartis-plunges-10-headed-for-worst-day-ever-afd57c?utm_source=bsky&utm_medium=social&utm_campaign=auto

🚨 Novartis Pelacarsen Heart Drug Misses Primary Endpoint

Novartis’ pelacarsen cardiovascular drug reportedly failed its primary endpoint, a…

#NVS

https://stop-fake.org/alerts/novartis-pelacarsen-heart-drug-misses-primary-endpoint-2bad46?utm_source=bsky&utm_medium=social&utm_campaign=auto